Concourse Financial Group Securities, Inc. Marker Therapeutics, Inc. Put Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.52 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MRKR
# of Institutions
5Shares Held
472KCall Options Held
0Put Options Held
0-
Act Capital Management, LLC Wayne, PA354KShares$1.76 Million0.18% of portfolio
-
Ar Asset Management Inc70.7KShares$351,3790.07% of portfolio
-
Personal Capital Advisors Corp25.7KShares$127,7880.0% of portfolio
-
American Portfolios Advisors Holbrook, NY21.2KShares$105,2140.0% of portfolio
About Marker Therapeutics, Inc.
- Ticker MRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,599,200
- Market Cap $415M
- Description
- Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...